1. Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis
   Chih-Yuan Fang et al, 2022, Pharmaceuticals CrossRef
2. An exotic pathogenetic mechanism of angiogenesis in oral lichen planus—A systematic review
   R. Keerthika et al, 2023, Journal of Oral Pathology & Medicine CrossRef
3. Deficiency of HtrA4 in BeWo cells downregulates angiogenesis through IL-6/JAK/STAT3 signaling
   Chang-Zhu Pei et al, 2023, Biomedicine & Pharmacotherapy CrossRef
4. Galectin‐3‐upregulated FAK promotes angiogenesis through oral lichen planus‐activated fibroblasts
   Xiaoheng Xu et al, 2024, Journal of Oral Pathology & Medicine CrossRef
5. Increased pathogenicity and pro-inflammatory capabilities of mucosal-associated invariant T cells involved in Oral Lichen Planus
   Siting Chen et al, 2024, BMC Oral Health CrossRef
6. MiR-155-5p modulates inflammatory phenotype of activated oral lichen-planus-associated-fibroblasts by targeting SOCS1
   Juehua Cheng et al, 2022, Molecular Biology Reports CrossRef
7. Probiotics as Potential Biological Immunomodulators in the Management of Oral Lichen Planus: What’s New?
   Paola Zanetta et al, 2022, International Journal of Molecular Sciences CrossRef
8. Comprehensive Insight into Lichen Planus Immunopathogenesis
   Marijana Vičić et al, 2023, International Journal of Molecular Sciences CrossRef
9. Comparative transcriptomic analysis validates iPSC derived in-vitro progressive fibrosis model as a screening tool for drug discovery and development in systemic sclerosis
   Shyam Nathan et al, 2024, Scientific Reports CrossRef
10. Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment
    Xiaoting Deng et al, 2023, Frontiers in Immunology CrossRef